Arterial Spin Labeling (ASL) perfusion MRI shows promise as a widely available and quantitative measure of resting brain function that can be used as a biomarker for the neural correlates of psychiatric and neurologic diseases, for the measurement of drug effects in the brain, and ultimately for diagnosis and treatment monitoring in individual patients. Although ASL perfusion MRI technologies are now implemented on most MRI scanner platforms, uncertainty in the community on the performance differences of various technical implementations and how to best use the technology across centers and MRI scanner platforms has limited its dissemination into routine use in clinical research. Building upon our successful development of quantification methods and standard sequences across platforms in the prior funding cycle, we propose to focus on the key issues limiting multi-center studies with ASL.
Our first aim i s to measure the relative sensitivity of different implementations of ASL by comparing their reproducibility and their response to 2 test interventions, citalopram or alprazolam administration. The result of this aim will be a quantitative calculation of power for detection of regional effects and how the choice of implementation will affect the power and required sample size.
The second aim i s to develop quality assessment methods using customized image acquisitions and the construction of a perfusion phantom. Quality assurance is a key element of imaging studies across sites, but there are no established methods for testing ASL perfusion performance. In our final aim, we target the characterization and reduction of variable perfusion signal induced by changes in brain activity unrelated to study interventions, so-called physiological noise. We will determine whether performing a moderately demanding vigilance task during the ASL scan will help control the subject's mental state and reduce variability without excessively stimulating particular regions of the brain. We will also study resting fluctuations in perfusion induced by network activity in the brain to determine if identifying and removing these fluctuations during image processing improves reproducibility.
This aim will also determine if the amplitude of resting fluctuations is reflective of resting perfusion. Since resting brain fluctuations as measured by blood oxygenation sensitive MRI are increasingly being used as an indicator of resting function, establishing a relationship between fluctuations and average resting activity will address an outstanding question in functional imaging. Achievement of these aims will accelerate and improve the use of ASL as a biomarker for brain function in disease and will greatly improve the design of numerous planned and active multi-site studies employing ASL.

Public Health Relevance

This proposal will improve a magnetic resonance imaging technique for seeing resting activity levels in regions of the brain. It is particularly focused on assuring the technique can be best used for studies at many different centers. These improvements will make possible more sensitive testing and study of drugs and other treatments for emotional and brain disorders, and potentially improved selection of treatments for individual patients.

National Institute of Health (NIH)
Research Project (R01)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Freund, Michelle
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Beth Israel Deaconess Medical Center
United States
Zip Code
Vidorreta, Marta; Balteau, Evelyne; Wang, Ze et al. (2014) Evaluation of segmented 3D acquisition schemes for whole-brain high-resolution arterial spin labeling at 3 T. NMR Biomed 27:1387-96
Wetherill, Reagan R; Jagannathan, Kanchana; Lohoff, Falk W et al. (2014) Neural correlates of attentional bias for smoking cues: modulation by variance in the dopamine transporter gene. Addict Biol 19:294-304
Franklin, Teresa R; Wang, Ze; Shin, Joshua et al. (2013) A VBM study demonstrating 'apparent' effects of a single dose of medication on T1-weighted MRIs. Brain Struct Funct 218:97-104
Dai, Weiying; Shankaranarayanan, Ajit; Alsop, David C (2013) Volumetric measurement of perfusion and arterial transit delay using hadamard encoded continuous arterial spin labeling. Magn Reson Med 69:1014-22
Detre, John A; Rao, Hengyi; Wang, Danny J J et al. (2012) Applications of arterial spin labeled MRI in the brain. J Magn Reson Imaging 35:1026-37
Musiek, Erik S; Chen, Yufen; Korczykowski, Marc et al. (2012) Direct comparison of fluorodeoxyglucose positron emission tomography and arterial spin labeling magnetic resonance imaging in Alzheimer's disease. Alzheimers Dement 8:51-9
Maleki, Nasim; Dai, Weiying; Alsop, David C (2012) Optimization of background suppression for arterial spin labeling perfusion imaging. MAGMA 25:127-33
Chen, Yufen; Wang, Danny J J; Detre, John A (2012) Comparison of arterial transit times estimated using arterial spin labeling. MAGMA 25:135-44
Dai, Weiying; Robson, Philip M; Shankaranarayanan, Ajit et al. (2012) Reduced resolution transit delay prescan for quantitative continuous arterial spin labeling perfusion imaging. Magn Reson Med 67:1252-65
Melzer, Tracy R; Watts, Richard; MacAskill, Michael R et al. (2011) Arterial spin labelling reveals an abnormal cerebral perfusion pattern in Parkinson's disease. Brain 134:845-55

Showing the most recent 10 out of 27 publications